81171

Gene analysis (fragile x mental retardation 2) for abnormal alleles

Medicare pricing data for 31 providers across 7 states

🤖AI Overview

Note: These costs reflect the Medicare physician/supplier component. Hospital facility fees are billed separately and can be 2-5x the physician fee.

💡 What You Should Know

Gene analysis (fragile x mental retardation 2) for abnormal alleles (HCPCS code 81171) is a medical procedure billed to Medicare. The average Medicare-allowed cost is $134.13, but hospitals typically charge $150.16 — a 1.1x markup. Prices vary significantly by state and provider.

🏷️ Typical Out-of-Pocket Cost

$26.83

Medicare patients typically pay about 20% of the allowed amount as coinsurance. Based on the average allowed cost of $134.13, your out-of-pocket cost would be approximately $26.83. Actual costs depend on your specific plan, deductible, and whether you've met your annual out-of-pocket maximum.

Average Allowed Cost
$134.13
Average Hospital Charge
$150.16
Markup Ratio
1.1x

What Hospitals Charge vs. What Medicare Pays

Hospital Charge$150.16
Medicare Allowed$134.13
Medicare Payment$134.13

Hospitals charge 1.1x more than what Medicare allows for this procedure. Medicare actually pays $134.13 on average.

Cost by State

Medicare-allowed amounts vary significantly by state

StateAllowed CostHospital ChargeProvidersServicesvs. National
Florida$134$1558820+0.1%
Louisiana$134$156263+0.1%
New Jersey$134$16633,020+0.1%
Oklahoma$134$1833242+0.1%
Pennsylvania$134$13711,101+0.1%
Arizona$134$200160+0.1%
Texas$134$141126,233-0.1%

⚠️ Important: These costs reflect the Medicare physician/supplier component. Hospital facility fees may be billed separately. Total out-of-pocket costs may be higher.

Related from TheDataProject.ai

💊 Need post-procedure medications? Check costs on OpenPrescriber